Determinants of cardiovascular mortality in a cohort of primary care patients with chronic ischemic heart disease. BARBANZA Ischemic Heart Disease (BARIHD) study

International Journal of Cardiology

Volumn 167, Issue 2, 2013, Pages 442-450

  Vidal Perez, Rafael ^a   Otero Raviña, Fernando ^b   Franco, Manuel ^c   Rodríguez Garcia, José M ^d   Stolle, Rosa Liñares ^e   Álvarez, Ramona Esteban ^f   Díaz, Cristina Iglesias ^g   López, Elena Outeiriño ^h   Vázquez López, María José ^f   Gonzalez Juanatey, José Ramón ^a  

^a University Hospital of Santiago de Compostela   (Spain)

^b Galician Health Service   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d Pobra Do Caramiñal Primary Care Centre   (Spain)

^e Bertamirans Primary Care Centre   (Spain)

^f Rianxo Primary Care Centre   (Spain)

^g Mera Primary Care Centre   (Spain)

^h Novoa Santos Primary Care Centre   (Spain)

Author keywords

Coronary artery disease; Primary care; Prognosis; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PRIMARY HEALTH CARE; SPAIN;

EID: 84879089298     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.01.014     Document Type: Article

References (33)

1. J. Marrugat, R. Elosúa, and H. Marti Epidemiology of ischaemic heart disease in Spain: estimation of the number of cases and trends from 1997 to 2005 Rev Esp Cardiol 55 2002 337 346
2. E.S. Ford, U.A. Ajani, and J.B. Croft Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398
3. I. Graham, D. Atar, and K. Borch-Johnsen European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice Eur Heart J 28 2007 2375 2414
4. S. Allender, P. Scharbotough, and V. Peto European cardiovascular disease statistics: 2008 edition 2008 British Heart Foundation London
5. J.M. Baena Díez, J.L. del Val Garcia, and J. Tomas Pelegrina Cardiovascular disease epidemiology and risk factors in primary care Rev Esp Cardiol 58 2005 367 373
6. K. Fox, M.A. Garcia, and D. Ardissino Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur Heart J 27 2006 1341 1381
7. EUROASPIRE Study Group EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries Eur J Cardiovasc Prev Rehabil 16 2009 121 137
8. A.D. Timmis, G. Feder, and H. Hemingway Prognosis of stable angina pectoris: why we need larger population studies with higher endpoint resolution Heart 93 2007 786 791
9. B. Buckley, and A.W. Murphy Do patients with angina alone have a more benign prognosis than patients with a history of acute myocardial infarction, revascularisation or both? Findings from a community cohort study Heart 95 2009 461 467
10. F. Otero-Raviña, L. Grigorian-Shamagian, and L. Fransi-Galiana Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP study Int J Cardiol 136 2009 56 63
11. R. Vidal-Pérez, F. Otero-Raviña, and L. Grigorian-Shamagian Sex does not influence prognosis in diabetic patients. The Barbanza Diabetes Study Rev Esp Cardiol 63 2010 170 180
12. A. García-Castelo, J. García-Seara, and F. Otero-Raviña Investigators prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study) Int J Cardiol 153 2011 68 73
13. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
14. Spanish National Institute of Vital Statistics, 2009. Instituto Nacional de estadística [web site]. Madrid: INE. [Result: 20 august 2009]. Available in: http://www.ine.es/.
15. W.E. Boden, R.A. O'Rourke, and K.K. Teo Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE trial) Am J Cardiol 104 2009 1 4
16. P.A. Poole-Wilson, Z. Vokó, B.A. Kirwan, S. de Brouwer, P.H. Dunselman, and J. Lubsen ACTION investigators. Clinical course of isolated stable angina due to coronary heart disease Eur Heart J 28 2007 1928 1935
17. B.S. Buckley, C.R. Simpson, D.J. McLernon, A.W. Murphy, and P.C. Hannaford Five year prognosis in patients with angina identified in primary care: incident cohort study BMJ 339 2009 b3058
18. H.M. Blackledge, and I.B. Squire Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: results from a large, population-based cohort with first intervention 1995-2004 Heart 95 2009 304 311
19. S. Jabbour, Y. Young-Xu, and T.B. Graboys Long-term outcomes of optimized medical management of outpatients with stable coronary artery disease Am J Cardiol 93 2004 294 299
20. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
21. D.T. Ko, D.A. Alter, and P.C. Austin Life expectancy after an index hospitalization for patients with heart failure: a population-based study Am Heart J 155 2008 324 331
22. A. Varela-Roman, J.R. Gonzalez-Juanatey, and P. Basante Clinical characteristics and prognosis of hospitalised inpatients with heart failure and preserved or reduced left ventricular ejection fraction Heart 88 2002 249 254
23. R. Huxley, F. Barzi, and M. Woodward Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies BMJ 332 2006 73 78
24. M.E. Farkouh, A. Aneja, and G.S. Reeder Usefulness of diabetes mellitus to predict long-term outcomes in patients with unstable angina pectoris Am J Cardiol 104 2009 492 497
25. M. Tonelli, P. Jose, G. Curhan, F. Sacks, E. Braunwald, and M. Pfeffer Cholesterol and Recurrent Events (CARE) Trial Investigators. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial BMJ 332 2006 1426
26. J.A. Jolliffe, K. Rees, R.S. Taylor, D. Thompson, N. Oldridge, and S. Ebrahim Exercise-based rehabilitation for coronary heart disease (Cochrane review) The Cochrane library, Issue 1 2003 Update Software Oxford
27. N. Freemantle, J. Cleland, P. Young, J. Mason, and J. Harrison Beta blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737
28. C. Daly, F. Clemens, and J.L. Lopez-Sendon The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina Eur Heart J 27 2006 1298 1304
29. Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a metaanalysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670-81.
30. M. Benderly, V. Boyko, and U. Goldbourt Relation of body mass index to mortality among men with coronary heart disease Am J Cardiol 106 2010 297 304
31. C.J. Lavie, R.V. Milani, and H.O. Ventura Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss J Am Coll Cardiol 53 2009 1925 1932
32. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
33. B. Buckley, A.W. Murphy, M. Byrne, and L. Glynn Selection bias resulting from the requirement for prior consent in observational research: a community cohort of people with ischaemic heart disease Heart 93 2007 1116 1120